Skip to main content
Premium Trial:

Request an Annual Quote

Genizon, Genome Quebec First to Join Illumina's Service Provider Program

NEW YORK (GenomeWeb News) — Illumina said today that Genizon Biosciences and Genome Quebec have been certified to offer genetic analysis services to researchers using its technologies.
The Canadian duo are the first members of Illumina's new CSPro Program, a service provider program that it said offers partners co-marketing benefits and a certification process.
According to Illumina, the CSPro program is modular and its members must be certified to offer certain assays: Genome Quebec is certified to offer its GoldenGate Genotyping assay, and Genizon BioSciences is certified to run GoldenGate assays and offer Illumina's Infinium whole-genome genotyping assay, which uses its HumanHap550 SNP chip.
Further financial details of the new program were not discussed.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.